Advisor Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $6K | Hold |
475
| – | – | ﹤0.01% | 4579 |
|
|
2019
Q3 | $5K | Buy |
475
+40
| +9% | +$421 | ﹤0.01% | 4680 |
|
|
2019
Q2 | $8K | Sell |
435
-54
| -11% | -$993 | ﹤0.01% | 4481 |
|
|
2019
Q1 | $16K | Buy |
489
+54
| +12% | +$1.77K | ﹤0.01% | 4097 |
|
|
2018
Q4 | $13K | Sell |
435
-380
| -47% | -$11.4K | ﹤0.01% | 4067 |
|
|
2018
Q3 | $50K | Sell |
815
-440
| -35% | -$27K | ﹤0.01% | 3292 |
|
|
2018
Q2 | $92K | Buy |
1,255
+575
| +85% | +$42.2K | ﹤0.01% | 2592 |
|
|
2018
Q1 | $45K | Buy |
680
+90
| +15% | +$5.96K | ﹤0.01% | 3143 |
|
|
2017
Q4 | $49K | Buy |
590
+425
| +258% | +$35.3K | ﹤0.01% | 3100 |
|
|
2017
Q3 | $20K | Buy |
165
+36
| +28% | +$4.36K | ﹤0.01% | 3567 |
|
|
2017
Q2 | $15K | Buy |
129
+2
| +2% | +$233 | ﹤0.01% | 3698 |
|
|
2017
Q1 | $15K | Buy |
127
+27
| +27% | +$3.19K | ﹤0.01% | 3559 |
|
|
2016
Q4 | $14K | Hold |
100
| – | – | ﹤0.01% | 3465 |
|
|
2016
Q3 | $20K | Hold |
100
| – | – | ﹤0.01% | 3157 |
|
|
2016
Q2 | $12K | Buy |
+100
| New | +$12K | ﹤0.01% | 3395 |
|